{"nctId":"NCT00417963","briefTitle":"ViVEXX Carotid Revascularization Trial (VIVA)","startDateStruct":{"date":"2005-10"},"conditions":["Carotid Artery Stenosis"],"count":407,"armGroups":[{"label":"stent placement in the carotid artery","type":"EXPERIMENTAL","interventionNames":["Device: Carotid Artery Stenting"]}],"interventions":[{"name":"Carotid Artery Stenting","otherNames":["CAS"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The patient has a symptomatic or asymptomatic carotid artery stenosis that meets one of the following criteria:\n\n  * Symptomatic: \\> than or = to 50% carotid stenosis by angiography and a history of non-disabling stroke, transient ischemic attack (TIA) in the hemisphere supplied by the target vessel within 180 days of the procedure.\n  * Asymptomatic: \\> than or = to 80% carotid stenosis by angiography without neurological symptoms.\n* High risk for carotid endarterectomy: anatomical and co-morbid.\n\nExclusion Criteria:\n\n* History of symptoms of stroke or TIA within 24 hours of the procedure\n* Extensive or diffuse atherosclerotic disease\n* Severe vascular tortuosity or anatomy that would preclude the safe introduction of the device","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Patients Experiencing Major Adverse Events (MAE)","description":"A composite of major adverse events (MAE) including any death, any stroke and/or myocardial infarction occurring during the first 30 days post-procedure and ipsilateral stroke between 31 and 365 days post procedure.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Experiencing Target Lesion Revascularization(s) (TLR)","description":"Number of participants experiencing a Target lesion revascularization(s) up to 12 months after implantation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"17","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients Experiencing Access Site Complications","description":"Access site complications requiring blood transfusion (\\> 1 unit) or open surgical repair.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Experiencing Stroke Related Neurologic Deficit","description":"Number of participants experiencing stroke related neurologic deficit persisting at 30 days and attributed to the index procedure.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Experiencing Device Success","description":"Number of participants with successful delivery and deployment of device with \\<50% residual stenosis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"462","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"462","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Experiencing Lesion Success","description":"number of participants experiencing achievement of \\<50% final residual diameter stenosis in the stented segment using the VIVEXX Carotid Stent and the Emboshield Embolic Protection System.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"473","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Experiencing Restenosis","description":"Number of participants experiencing Restenosis following placement of the ViVexx Carotid Stent.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"43","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":316,"n":486},"commonTop":["Hypotension","Anaemia","CArdiac failure congestive","Mycardial infarction","Hypertension"]}}}